Cite
Additional file 1: Table S1. of Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database
MLA
Sangjin Shin, et al. Additional File 1: Table S1. of Erlotinib plus Gemcitabine versus Gemcitabine for Pancreatic Cancer: Real-World Analysis of Korean National Database. Jan. 2016. EBSCOhost, https://doi.org/10.6084/m9.figshare.c.3611783_d1.v1.
APA
Sangjin Shin, Park, C., Hanbyeol Kwon, & Kyung-Hun Lee. (2016). Additional file 1: Table S1. of Erlotinib plus gemcitabine versus gemcitabine for pancreatic cancer: real-world analysis of Korean national database. https://doi.org/10.6084/m9.figshare.c.3611783_d1.v1
Chicago
Sangjin Shin, Chan Park, Hanbyeol Kwon, and Kyung-Hun Lee. 2016. “Additional File 1: Table S1. of Erlotinib plus Gemcitabine versus Gemcitabine for Pancreatic Cancer: Real-World Analysis of Korean National Database,” January. doi:10.6084/m9.figshare.c.3611783_d1.v1.